Emerging therapeutic potential for xenin and related peptides in obesity and diabetes
- S. L. Craig; V. A. Gault; N. Irwin Emerging therapeutic potential for xenin and related peptides in obesity and diabetes Diabetes Metab Res Rev
Publication Category: Medications
Recent advances in peptide-based therapy for Type 2 diabetes and obesity
- J. M. Conlon; P. R. Flatt; C. J. Bailey Recent advances in peptide-based therapy for Type 2 diabetes and obesity Peptides
Impact of leucine on energy balance
-
L. McAllan; P. D. Cotter; H. M. Roche; R. Korpela; K. N. Nilaweera
Impact of leucine on energy balance J Physiol Biochem
The probiotic L. casei LC-XCAL™ improves metabolic health in a diet-induced obesity mouse model without altering the microbiome
-
C. J. Walsh; S. Healy; P. W. O’Toole; E. F. Murphy; P. D. Cotter
The probiotic L. casei LC-XCAL™ improves metabolic health in a diet-induced obesity mouse model without altering the microbiome Gut Microbes
Gut microbiota modulation with long-chain corn bran arabinoxylan in adults with overweight and obesity is linked to an individualized temporal increase in fecal propionate
-
N. K. Nguyen; E. C. Deehan; Z. Zhang; M. Jin; N. Baskota; M. E. Perez-Muñoz; J. Cole; Y. E. Tuncil; B. Seethaler; T. Wang; M. Laville; N. M. Delzenne; S. C. Bischoff; B. R. Hamaker; I. Martínez; D. Knights; J. A. Bakal; C. M. Prado; J. Walter
Gut microbiota modulation with long-chain corn bran arabinoxylan in adults with overweight and obesity is linked to an individualized temporal increase in fecal propionate Microbiome
Antimicrobials: Strategies for targeting obesity and metabolic health?
-
E. F. Murphy; S. F. Clarke; T. M. Marques; C. Hill; C. Stanton; R. P. Ross; R. M. O'Doherty; F. Shanahan; P. D. Cotter
Antimicrobials: Strategies for targeting obesity and metabolic health? Gut Microbes
Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity
-
E. F. Murphy; P. D. Cotter; A. Hogan; O. O'Sullivan; A. Joyce; F. Fouhy; S. F. Clarke; T. M. Marques; P. W. O'Toole; C. Stanton; E. M. M. Quigley; C. Daly; P. R. Ross; R. M. O'Doherty; F. Shanahan
Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity Gut
Type 2 diabetes: multimodal treatment of a complex disease
- D. J. Pournaras; C. W. le Roux Type 2 diabetes: multimodal treatment of a complex disease Lancet
Review of multimodal treatment for type 2 diabetes: combining metabolic surgery and pharmacotherapy
- A. Sudlow; C. W. le Roux; D. J. Pournaras Review of multimodal treatment for type 2 diabetes: combining metabolic surgery and pharmacotherapy Ther Adv Endocrinol Metab